NASDAQ: INDPIndaptus Therapeutics Inc Stock Ownership - Who owns Indaptus Therapeutics?
Insider buying vs selling
Have Indaptus Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Walt Addison Linscott | Chief Operating Officer | 2025-12-22 | 54,421 | $2.03 | $110.47kBuy |
| Jeffrey A. Meckler | Co-Chief Executive Officer | 2025-12-22 | 216,617 | $2.03 | $439.73kBuy |
| Michael James Newman | CSO and Director | 2025-12-22 | 52,204 | $2.03 | $105.97kBuy |
| Nir Sassi | Chief Financial Officer | 2025-12-22 | 26,758 | $2.03 | $54.32kBuy |
| Jeffrey A. Meckler | Chief Executive Officer | 2025-07-27 | 6,068 | $8.30 | $50.38kBuy |
INDP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INDP insiders and whales buy or sell their stock.
INDP Shareholders
What type of owners hold Indaptus Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yun Yao | 1,872.66% | 41,991,000 | $113.80M | Insider |
| Sino Lion Ventures Ltd | 1,734.58% | 38,895,000 | $105.41M | Insider |
| Junyi Dai | 501.71% | 11,250,000 | $30.49M | Insider |
| Dexcel Pharma Technologies Ltd | 188.86% | 4,234,897 | $11.48M | Insider |
| Michael James Newman | 65.53% | 1,469,430 | $3.98M | Insider |
| Glen R. Anderson | 58.17% | 1,304,318 | $3.53M | Insider |
| Jeffrey A. Meckler | 10.25% | 229,929 | $623.11k | Insider |
| John W. Kozarich | 6.77% | 151,761 | $411.27k | Insider |
| Walt Addison Linscott | 2.43% | 54,426 | $147.49k | Insider |
| Anthony J. Maddaluna | 2.39% | 53,570 | $145.17k | Insider |
INDP vs Biotech Stocks
Indaptus Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.